HRS-7058

DRUG4 trials

Sponsors

Shandong Suncadia Medicine Co., Ltd., Fudan University

Conditions

KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard TreatmentLocally Advanced Colorectal CancerPancreatic CancerSolid Tumors

Phase 2

A Clinical Trial of HRS-7058 Combined Anti-tumor Drugs in Subjects With Solid Tumors

RecruitingNCT07032077

Shandong Suncadia Medicine Co., Ltd.Solid Tumors

Start: 2025-07-09End: 2027-07-01Target: 100Updated: 2026-03-20

Umbrella Trial of Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

Not yet recruitingNCT07503639

Fudan UniversityLocally Advanced Colorectal Cancer

Start: 2026-04-01End: 2030-04-01Target: 134Updated: 2026-03-31

An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With Pancreatic Cancer

Not yet recruitingNCT07589569

Shandong Suncadia Medicine Co., Ltd.Pancreatic Cancer

Start: 2026-05-01End: 2028-12-01Target: 92Updated: 2026-05-15

Phase 3

A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment

Not yet recruitingNCT07601048

Shandong Suncadia Medicine Co., Ltd.KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment

Start: 2026-06-01End: 2029-05-01Target: 450Updated: 2026-05-22